1 | final | 8,426 |
2 | base-case | 198 |
3 | test-of-cure | 106 |
4 | holy | 59 |
5 | pennes | 29 |
6 | lightsheer | 16 |
7 | no-difference | 13 |
8 | intratest | 10 |
9 | four-variable | 9 |
10 | 3-component | 8 |
11 | angioscopic | 8 |
12 | two-temperature | 8 |
13 | 63-day | 7 |
14 | cost-offset | 7 |
15 | bifactor | 6 |
16 | euroncap | 6 |
17 | food-addiction | 6 |
18 | wellfocus | 6 |
19 | 6-8-week | 5 |
20 | anamorphic | 5 |
21 | baropodometric | 5 |
22 | booking-in | 5 |
23 | full-dimensional | 5 |
24 | intra-annual | 5 |
25 | propensity-based | 5 |
26 | 100-cm | 4 |
27 | aesthetical | 4 |
28 | densest | 4 |
29 | early-therapy | 4 |
30 | late-posttherapy | 4 |
31 | midilli | 4 |
32 | pedographic | 4 |
33 | point-based | 4 |
34 | post-bronchoscopy | 4 |
35 | well-woman | 4 |
36 | conceptus-adjusted | 3 |
37 | cortisole | 3 |
38 | end-performance | 3 |
39 | hempel | 3 |
40 | inital | 3 |
41 | lithium-rich | 3 |
42 | longest-term | 3 |
43 | per-biopsy | 3 |
44 | tackley | 3 |
45 | trace-level | 3 |
46 | 'assimilation | 2 |
47 | 0.30-mg | 2 |
48 | 1,100-microg | 2 |
49 | 1-pl | 2 |
50 | 110-mg | 2 |
51 | 1n-transformed | 2 |
52 | 2-liter | 2 |
53 | 2-tissue-compartment | 2 |
54 | 28-wk | 2 |
55 | 35-cm | 2 |
56 | 6-variable | 2 |
57 | common/local | 2 |
58 | competition-mediated | 2 |
59 | enamel/crown | 2 |
60 | fifth-day | 2 |
61 | identitas | 2 |
62 | implant-wise | 2 |
63 | late-posttreatment | 2 |
64 | lh-t | 2 |
65 | microvertebrate | 2 |
66 | mizuno | 2 |
67 | obesity-independent | 2 |
68 | pbat | 2 |
69 | pentose-based | 2 |
70 | pragmatistic | 2 |
71 | pre-fixed | 2 |
72 | prechiasmatic | 2 |
73 | rapid-pacing | 2 |
74 | rayman | 2 |
75 | recipe-syndrome | 2 |
76 | slowest-heating | 2 |
77 | trypanosome-induced | 2 |
78 | utci-fiala | 2 |
79 | wet-granulated | 2 |
80 | 0-hour | 1 |
81 | 0.2mg/kg/dose | 1 |
82 | 0.75-1.0mg/kg | 1 |
83 | 0.76-mm | 1 |
84 | 1.50±0.05 | 1 |
85 | 10.7-cm | 1 |
86 | 10.8g | 1 |
87 | 12/final | 1 |
88 | 2-10mg | 1 |
89 | 3-year-in-function | 1 |
90 | 300-day | 1 |
91 | 36th-week | 1 |
92 | 5.5mg/kg | 1 |
93 | 87,573 | 1 |
94 | 9-12-week | 1 |
95 | au/sn | 1 |
96 | capacity-distance | 1 |
97 | case-adjusted | 1 |
98 | dehalococcoides-like | 1 |
99 | discharge/transfer | 1 |
100 | disribution | 1 |
101 | dr5-selective | 1 |
102 | early-dividing | 1 |
103 | eid-associated | 1 |
104 | ev/expected | 1 |
105 | fastest-moving | 1 |
106 | frith-happé | 1 |
107 | globular-stage | 1 |
108 | hab-positive | 1 |
109 | half-doped | 1 |
110 | high-papr | 1 |
111 | hiv-detection | 1 |
112 | inpc | 1 |
113 | is-inserted | 1 |
114 | kantonales | 1 |
115 | klinikum | 1 |
116 | late-ring/early | 1 |
117 | led-induced | 1 |
118 | less-differentiated | 1 |
119 | lung-screening | 1 |
120 | lymphatic-related | 1 |
121 | malvaceous-plant-infecting | 1 |
122 | medicare-approved | 1 |
123 | metamorphosing | 1 |
124 | month-2 | 1 |
125 | nonadministration | 1 |
126 | oasis-c. | 1 |
127 | ontreatment | 1 |
128 | ottowa | 1 |
129 | phenyl-pyrrole | 1 |
130 | polymer-plasmid-dna | 1 |
131 | post-clinic | 1 |
132 | post-therapy/toc | 1 |
133 | postcommissural | 1 |
134 | posttherapy/toc | 1 |
135 | pre-implantational | 1 |
136 | preattachment | 1 |
137 | pregastrula | 1 |
138 | randomization/baseline | 1 |
139 | resistance-compliance | 1 |
140 | rye-grass | 1 |
141 | self-unrelated | 1 |
142 | seven-up | 1 |
143 | shirom | 1 |
144 | taboul | 1 |
145 | test-of-treatment | 1 |
146 | zigzag-line | 1 |
147 | ~6-h | 1 |
1 | 'assimilation | 2 |
2 | 0-hour | 1 |
3 | 0.2mg/kg/dose | 1 |
4 | 0.30-mg | 2 |
5 | 0.75-1.0mg/kg | 1 |
6 | 0.76-mm | 1 |
7 | 1,100-microg | 2 |
8 | 1-pl | 2 |
9 | 1.50±0.05 | 1 |
10 | 10.7-cm | 1 |
11 | 10.8g | 1 |
12 | 100-cm | 4 |
13 | 110-mg | 2 |
14 | 12/final | 1 |
15 | 1n-transformed | 2 |
16 | 2-10mg | 1 |
17 | 2-liter | 2 |
18 | 2-tissue-compartment | 2 |
19 | 28-wk | 2 |
20 | 3-component | 8 |
21 | 3-year-in-function | 1 |
22 | 300-day | 1 |
23 | 35-cm | 2 |
24 | 36th-week | 1 |
25 | 5.5mg/kg | 1 |
26 | 6-8-week | 5 |
27 | 6-variable | 2 |
28 | 63-day | 7 |
29 | 87,573 | 1 |
30 | 9-12-week | 1 |
31 | aesthetical | 4 |
32 | anamorphic | 5 |
33 | angioscopic | 8 |
34 | au/sn | 1 |
35 | baropodometric | 5 |
36 | base-case | 198 |
37 | bifactor | 6 |
38 | booking-in | 5 |
39 | capacity-distance | 1 |
40 | case-adjusted | 1 |
41 | common/local | 2 |
42 | competition-mediated | 2 |
43 | conceptus-adjusted | 3 |
44 | cortisole | 3 |
45 | cost-offset | 7 |
46 | dehalococcoides-like | 1 |
47 | densest | 4 |
48 | discharge/transfer | 1 |
49 | disribution | 1 |
50 | dr5-selective | 1 |
51 | early-dividing | 1 |
52 | early-therapy | 4 |
53 | eid-associated | 1 |
54 | enamel/crown | 2 |
55 | end-performance | 3 |
56 | euroncap | 6 |
57 | ev/expected | 1 |
58 | fastest-moving | 1 |
59 | fifth-day | 2 |
60 | final | 8,426 |
61 | food-addiction | 6 |
62 | four-variable | 9 |
63 | frith-happé | 1 |
64 | full-dimensional | 5 |
65 | globular-stage | 1 |
66 | hab-positive | 1 |
67 | half-doped | 1 |
68 | hempel | 3 |
69 | high-papr | 1 |
70 | hiv-detection | 1 |
71 | holy | 59 |
72 | identitas | 2 |
73 | implant-wise | 2 |
74 | inital | 3 |
75 | inpc | 1 |
76 | intra-annual | 5 |
77 | intratest | 10 |
78 | is-inserted | 1 |
79 | kantonales | 1 |
80 | klinikum | 1 |
81 | late-posttherapy | 4 |
82 | late-posttreatment | 2 |
83 | late-ring/early | 1 |
84 | led-induced | 1 |
85 | less-differentiated | 1 |
86 | lh-t | 2 |
87 | lightsheer | 16 |
88 | lithium-rich | 3 |
89 | longest-term | 3 |
90 | lung-screening | 1 |
91 | lymphatic-related | 1 |
92 | malvaceous-plant-infecting | 1 |
93 | medicare-approved | 1 |
94 | metamorphosing | 1 |
95 | microvertebrate | 2 |
96 | midilli | 4 |
97 | mizuno | 2 |
98 | month-2 | 1 |
99 | no-difference | 13 |
100 | nonadministration | 1 |
101 | oasis-c. | 1 |
102 | obesity-independent | 2 |
103 | ontreatment | 1 |
104 | ottowa | 1 |
105 | pbat | 2 |
106 | pedographic | 4 |
107 | pennes | 29 |
108 | pentose-based | 2 |
109 | per-biopsy | 3 |
110 | phenyl-pyrrole | 1 |
111 | point-based | 4 |
112 | polymer-plasmid-dna | 1 |
113 | post-bronchoscopy | 4 |
114 | post-clinic | 1 |
115 | post-therapy/toc | 1 |
116 | postcommissural | 1 |
117 | posttherapy/toc | 1 |
118 | pragmatistic | 2 |
119 | pre-fixed | 2 |
120 | pre-implantational | 1 |
121 | preattachment | 1 |
122 | prechiasmatic | 2 |
123 | pregastrula | 1 |
124 | propensity-based | 5 |
125 | randomization/baseline | 1 |
126 | rapid-pacing | 2 |
127 | rayman | 2 |
128 | recipe-syndrome | 2 |
129 | resistance-compliance | 1 |
130 | rye-grass | 1 |
131 | self-unrelated | 1 |
132 | seven-up | 1 |
133 | shirom | 1 |
134 | slowest-heating | 2 |
135 | taboul | 1 |
136 | tackley | 3 |
137 | test-of-cure | 106 |
138 | test-of-treatment | 1 |
139 | trace-level | 3 |
140 | trypanosome-induced | 2 |
141 | two-temperature | 8 |
142 | utci-fiala | 2 |
143 | well-woman | 4 |
144 | wellfocus | 6 |
145 | wet-granulated | 2 |
146 | zigzag-line | 1 |
147 | ~6-h | 1 |
1 | oasis-c. | 1 |
2 | month-2 | 1 |
3 | 87,573 | 1 |
4 | 1.50±0.05 | 1 |
5 | utci-fiala | 2 |
6 | pregastrula | 1 |
7 | polymer-plasmid-dna | 1 |
8 | ottowa | 1 |
9 | pedographic | 4 |
10 | anamorphic | 5 |
11 | post-clinic | 1 |
12 | angioscopic | 8 |
13 | baropodometric | 5 |
14 | prechiasmatic | 2 |
15 | pragmatistic | 2 |
16 | post-therapy/toc | 1 |
17 | posttherapy/toc | 1 |
18 | inpc | 1 |
19 | led-induced | 1 |
20 | trypanosome-induced | 2 |
21 | 1n-transformed | 2 |
22 | half-doped | 1 |
23 | pentose-based | 2 |
24 | point-based | 4 |
25 | propensity-based | 5 |
26 | eid-associated | 1 |
27 | competition-mediated | 2 |
28 | less-differentiated | 1 |
29 | lymphatic-related | 1 |
30 | self-unrelated | 1 |
31 | wet-granulated | 2 |
32 | ev/expected | 1 |
33 | is-inserted | 1 |
34 | case-adjusted | 1 |
35 | conceptus-adjusted | 3 |
36 | medicare-approved | 1 |
37 | pre-fixed | 2 |
38 | resistance-compliance | 1 |
39 | end-performance | 3 |
40 | capacity-distance | 1 |
41 | no-difference | 13 |
42 | globular-stage | 1 |
43 | dehalococcoides-like | 1 |
44 | 6-variable | 2 |
45 | four-variable | 9 |
46 | phenyl-pyrrole | 1 |
47 | cortisole | 3 |
48 | recipe-syndrome | 2 |
49 | zigzag-line | 1 |
50 | randomization/baseline | 1 |
51 | test-of-cure | 106 |
52 | two-temperature | 8 |
53 | base-case | 198 |
54 | implant-wise | 2 |
55 | 0.2mg/kg/dose | 1 |
56 | microvertebrate | 2 |
57 | dr5-selective | 1 |
58 | hab-positive | 1 |
59 | 10.8g | 1 |
60 | 0.75-1.0mg/kg | 1 |
61 | 5.5mg/kg | 1 |
62 | 110-mg | 2 |
63 | 0.30-mg | 2 |
64 | 2-10mg | 1 |
65 | rapid-pacing | 2 |
66 | early-dividing | 1 |
67 | lung-screening | 1 |
68 | metamorphosing | 1 |
69 | slowest-heating | 2 |
70 | malvaceous-plant-infecting | 1 |
71 | fastest-moving | 1 |
72 | 1,100-microg | 2 |
73 | ~6-h | 1 |
74 | lithium-rich | 3 |
75 | midilli | 4 |
76 | 9-12-week | 1 |
77 | 6-8-week | 5 |
78 | 36th-week | 1 |
79 | 28-wk | 2 |
80 | aesthetical | 4 |
81 | common/local | 2 |
82 | final | 8,426 |
83 | 12/final | 1 |
84 | full-dimensional | 5 |
85 | pre-implantational | 1 |
86 | postcommissural | 1 |
87 | inital | 3 |
88 | intra-annual | 5 |
89 | hempel | 3 |
90 | trace-level | 3 |
91 | 1-pl | 2 |
92 | taboul | 1 |
93 | 100-cm | 4 |
94 | 35-cm | 2 |
95 | 10.7-cm | 1 |
96 | 0.76-mm | 1 |
97 | shirom | 1 |
98 | longest-term | 3 |
99 | klinikum | 1 |
100 | well-woman | 4 |
101 | rayman | 2 |
102 | booking-in | 5 |
103 | 'assimilation | 2 |
104 | nonadministration | 1 |
105 | hiv-detection | 1 |
106 | food-addiction | 6 |
107 | 3-year-in-function | 1 |
108 | disribution | 1 |
109 | au/sn | 1 |
110 | enamel/crown | 2 |
111 | mizuno | 2 |
112 | euroncap | 6 |
113 | seven-up | 1 |
114 | lightsheer | 16 |
115 | discharge/transfer | 1 |
116 | 2-liter | 2 |
117 | bifactor | 6 |
118 | high-papr | 1 |
119 | 0-hour | 1 |
120 | identitas | 2 |
121 | kantonales | 1 |
122 | pennes | 29 |
123 | rye-grass | 1 |
124 | wellfocus | 6 |
125 | lh-t | 2 |
126 | pbat | 2 |
127 | cost-offset | 7 |
128 | obesity-independent | 2 |
129 | preattachment | 1 |
130 | test-of-treatment | 1 |
131 | ontreatment | 1 |
132 | late-posttreatment | 2 |
133 | 2-tissue-compartment | 2 |
134 | 3-component | 8 |
135 | densest | 4 |
136 | intratest | 10 |
137 | 300-day | 1 |
138 | 63-day | 7 |
139 | fifth-day | 2 |
140 | tackley | 3 |
141 | holy | 59 |
142 | late-ring/early | 1 |
143 | early-therapy | 4 |
144 | late-posttherapy | 4 |
145 | post-bronchoscopy | 4 |
146 | per-biopsy | 3 |
147 | frith-happé | 1 |